Outset Medical, Inc. (NASDAQ:OM – Get Free Report) CFO Renee Gaeta sold 4,498 shares of Outset Medical stock in a transaction on Monday, November 16th. The shares were sold at an average price of $3.67, for a total transaction of $16,507.66. Following the sale, the chief financial officer directly owned 176,342 shares of the company’s stock, valued at $647,175.14. This trade represents a 2.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Outset Medical Price Performance
Shares of Outset Medical stock traded down $0.23 on Tuesday, hitting $3.16. 142,514 shares of the company traded hands, compared to its average volume of 107,148. Outset Medical, Inc. has a 12-month low of $2.84 and a 12-month high of $6.49. The company has a current ratio of 4.86, a quick ratio of 3.85 and a debt-to-equity ratio of 1.19. The company has a 50-day moving average price of $3.75 and a 200 day moving average price of $4.09.
Outset Medical (NASDAQ:OM – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported ($0.68) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.69) by $0.01. Outset Medical had a negative return on equity of 66.98% and a negative net margin of 58.33%. The business had revenue of $33.60 million during the quarter, compared to analyst estimates of $31.40 million. As a group, equities research analysts predict that Outset Medical, Inc. will post -3.51 EPS for the current year.
Institutional Trading of Outset Medical
Several large investors have recently added to or reduced their stakes in OM. Empowered Funds LLC bought a new stake in Outset Medical in the third quarter worth approximately $74,000. Squarepoint Ops LLC bought a new position in shares of Outset Medical during the 2nd quarter valued at $98,000. Bank of New York Mellon Corp bought a new position in shares of Outset Medical during the 2nd quarter valued at $121,000. Sei Investments Co. raised its holdings in shares of Outset Medical by 15.5% during the 1st quarter. Sei Investments Co. now owns 35,366 shares of the company’s stock valued at $136,000 after purchasing an additional 4,738 shares in the last quarter. Finally, Marquette Asset Management LLC acquired a new stake in shares of Outset Medical in the 2nd quarter valued at $212,000.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. Weiss Ratings lowered Outset Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, August 21st. Wall Street Zen raised Outset Medical from a “sell” rating to a “hold” rating in a research note on Saturday, August 15th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Outset Medical currently has an average rating of “Hold” and a consensus target price of $10.00.
Read Our Latest Stock Report on Outset Medical
About Outset Medical
Outset Medical is a medical technology company that develops and sells products for hemodialysis, a treatment that filters waste and excess fluid from the blood. Its main product is the Tablo Hemodialysis System, an integrated dialysis platform designed for use in hospitals, clinics and home settings. Tablo combines dialysis equipment with water purification and a touchscreen interface, aiming to simplify treatment setup and operation. The system also supports access to treatment data through connected software tools.
See Also
- Five stocks we like better than Outset Medical
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.
